Lateral Geniculate Nucleus Volume Assessed by 7 Tesla MRI 3D MT-Weighted SILENT Protocol in Patients with STARGARDT
Agata Szpringer-Wabicz1, Katarzyna Nowomiejska1, Anna Niedziałek2
1Chair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20-079 Lublin, Poland.
Journal of Clinical Medicine
|August 28, 2025
Summary
Patients with Stargardt disease (STGD) show reduced lateral geniculate nucleus (LGN) volume on 7 Tesla MRI scans. This finding suggests LGN volume may serve as a biomarker for STGD progression and treatment response.
Area of Science:
- Neuroimaging
- Ophthalmology
- Neurology
Background:
- Stargardt disease (STGD) is a leading inherited retinal dystrophy.
- Structural changes in the brain, particularly the lateral geniculate nucleus (LGN), are increasingly recognized in STGD.
- Quantitative assessment of LGN volume can provide insights into disease mechanisms.
Purpose of the Study:
- To quantitatively assess lateral geniculate nucleus (LGN) volume using 7 Tesla (7T) MRI in patients with Stargardt disease (STGD).
- To compare LGN volume and its ratio to thalamus volume between STGD patients and healthy controls.
- To explore the potential of 7T MRI as a biomarker for STGD.
Main Methods:
- 18 patients with STGD and 15 healthy controls underwent brain 7T MRI.
- Manual segmentation of LGN volume using ITK-SNAP software by three independent radiologists.
- Automated evaluation of thalamus volume using FreeSurfer software.
- Preceding ophthalmic examination and 1.5T MRI were performed.
Main Results:
- Significantly smaller average LGN volumes were observed in both hemispheres of STGD patients compared to controls (p < 0.0001).
- The right LGN/thalamus volume ratio was significantly lower in STGD patients (0.014) than in controls (0.017) (p = 0.024).
- 7T MRI revealed significant structural differences in the LGN of STGD patients.
Conclusions:
- Right and left LGN volumes are reduced in STGD patients compared to controls, as shown by 7T MRI.
- The right LGN/thalamus ratio is also significantly reduced in STGD patients.
- 3D MT-weighted SILENT 7T MRI offers novel insights into brain structural changes in STGD and may serve as a marker for future therapy response.


